Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON

View ORCID ProfileAsaf Poran, Dewi Harjanto, Matthew Malloy, Michael S. Rooney, Lakshmi Srinivasan, Richard B. Gaynor
doi: https://doi.org/10.1101/2020.04.06.027805
Asaf Poran
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Asaf Poran
  • For correspondence: aporan@neontherapeutics.com dharjanto@neontherapeutics.com
Dewi Harjanto
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aporan@neontherapeutics.com dharjanto@neontherapeutics.com
Matthew Malloy
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Rooney
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshmi Srinivasan
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard B. Gaynor
Neon Therapeutics, Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Background The ongoing COVID-19 pandemic has created an urgency to identify novel vaccine targets for protective immunity against SARS-CoV-2. Consistent with observations for SARS-CoV, a closely related coronavirus responsible for the 2003 SARS outbreak, early reports identify a protective role for both humoral and cell-mediated immunity for SARS CoV-2.

Methods In this study, we leveraged HLA-I and HLA-II T cell epitope prediction tools from RECON® (Real-time Epitope Computation for ONcology), our bioinformatic pipeline that was developed using proteomic profiling of individual HLA-I and HLA-II alleles to predict rules for peptide binding to a diverse set of such alleles. We applied these binding predictors to viral genomes from the Coronaviridae family, and specifically to identify SARS-CoV-2 T cell epitopes.

Results To test the suitability of these tools to identify viral T cell epitopes, we first validated HLA-I and HLA-II predictions on Coronaviridae family epitopes deposited in the Virus Pathogen Database and Analysis Resource (ViPR) database. We then use our HLA-I and HLA-II predictors to identify 11,776 HLA-I and 7,991 HLA-II candidate binding peptides across all 12 open reading frames (ORFs) of SARS-CoV-2. This extensive list of identified candidate peptides is driven by the length of the ORFs and the significant number of HLA-I and HLA-II alleles that we are able to predict (74 and 83, respectively), providing over 99% coverage for the US, European and Asian populations, for both HLA-I and HLA-II. From our SARS-CoV-2 predicted peptide-HLA-I allele pairs, 368 pairs identically matched previously reported pairs in the ViPR database, originating from other forms of coronaviruses. 320 of these pairs (89.1%) had a positive MHC-binding assay result. This analysis reinforces the validity our predictions.

Conclusions Using this bioinformatic platform, we identify multiple putative epitopes for CD4+ and CD8+ T cells whose HLA binding properties cover nearly the entire population and thus may be effective when included in prophylactic vaccines against SARS-CoV-2 to induce broad cellular immunity.

  • List of Abbreviations

    S
    Human Leukocyte Antigen
    MERS-CoV
    Middle East Respiratory Syndrome – Coronavirus
    MHC
    Major histocompatibility complex
    RECON
    Real-time Epitope Computation for ONcology
    SARS-CoV
    Severe Acute Respiratory Syndrome – Coronavirus
    SARS-CoV-2
    Severe Acute Respiratory Syndrome – Coronavirus – 2
    USA
    United States of America
    ViPR
    Virus Pathogen Resource
    WHO
    World Health Organization
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 08, 2020.
    Download PDF

    Supplementary Material

    Email

    Thank you for your interest in spreading the word about bioRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON
    (Your Name) has forwarded a page to you from bioRxiv
    (Your Name) thought you would like to see this page from the bioRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON
    Asaf Poran, Dewi Harjanto, Matthew Malloy, Michael S. Rooney, Lakshmi Srinivasan, Richard B. Gaynor
    bioRxiv 2020.04.06.027805; doi: https://doi.org/10.1101/2020.04.06.027805
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON
    Asaf Poran, Dewi Harjanto, Matthew Malloy, Michael S. Rooney, Lakshmi Srinivasan, Richard B. Gaynor
    bioRxiv 2020.04.06.027805; doi: https://doi.org/10.1101/2020.04.06.027805

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Bioinformatics
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (4383)
    • Biochemistry (9599)
    • Bioengineering (7094)
    • Bioinformatics (24865)
    • Biophysics (12615)
    • Cancer Biology (9958)
    • Cell Biology (14354)
    • Clinical Trials (138)
    • Developmental Biology (7950)
    • Ecology (12107)
    • Epidemiology (2067)
    • Evolutionary Biology (15989)
    • Genetics (10926)
    • Genomics (14743)
    • Immunology (9870)
    • Microbiology (23676)
    • Molecular Biology (9485)
    • Neuroscience (50872)
    • Paleontology (369)
    • Pathology (1539)
    • Pharmacology and Toxicology (2683)
    • Physiology (4016)
    • Plant Biology (8657)
    • Scientific Communication and Education (1509)
    • Synthetic Biology (2397)
    • Systems Biology (6436)
    • Zoology (1346)